CXCR3

CXCR3 詳細

英語名C-X-C motif chemokine receptor 3市販薬剤の数0
治験薬の数2ターゲットの別称CKR-L2,G protein-coupled receptor 9,IP-10 receptor,CXCR-3,CXC-R3,CXCR3,C-X-C Motif Chemokine Receptor 3,Interferon-Inducible Protein 10 Receptor,GPR9,C-X-C Chemokine Receptor Type 3,Chemokine Receptor 3,CD183 Antigen,CMKAR3,Chemokine (C-X-C Motif) Receptor 3,Mig Receptor,IP10-R,CD182,CD183,Mig-R,MigR,Receptors, CXCR3
研究&開発段階Phase 1 Clinical
英語名C-X-C motif chemokine receptor 3
ターゲットの別称CKR-L2,G protein-coupled receptor 9,IP-10 receptor,CXCR-3,CXC-R3,CXCR3,C-X-C Motif Chemokine Receptor 3,Interferon-Inducible Protein 10 Receptor,GPR9,C-X-C Chemokine Receptor Type 3,Chemokine Receptor 3,CD183 Antigen,CMKAR3,Chemokine (C-X-C Motif) Receptor 3,Mig Receptor,IP10-R,CD182,CD183,Mig-R,MigR,Receptors, CXCR3
市販薬剤の数0
治験薬の数2
研究&開発段階Phase 1 Clinical

CXCR3 製品リスト

  • 属性

    Protein (4)Cell (2)

  • 製品ライブラリ

    オンライン (6)

  • Human (5)Mouse (1)

  • タグ

    - (5)His Tag & Flag Tag (1)

  • マーカー

    Unconjugated (3)- (2)Biotin-labeled (1)

製品番号発現システム製品説明タンパク質の構造純度特性
HOT
AI Compatible
CX3-H52D5
Human
HEK293
Human CXCR3 Protein, Flag,His Tag (Detergent)
Human
CHO
CHO/Human CXCR3 Stable Cell Line
AI Compatible
CHEK-ATP253
Human
HEK293
HEK293/Human CXCR3 Stable Cell Line
AI Compatible
CX3-H52P4
Human
HEK293
Human CXCR3 Full Length Protein (VLP)
AI Compatible
CX3-H82P3
Human
HEK293
Biotinylated Human CXCR3 Full Length Protein (VLP)
AI Compatible
CX3-M52P7
Mouse
HEK293
Mouse CXCR3 Full Length Protein (VLP)
総数量6
  • 1

CXCR3バックグランド

Chemokines are proteins which induce chemotaxis, promote differentiation of immune cells, and cause tissue extravasation. Given these properties, their role in anti-tumor immune response in the cancer environment is of great interest. Although immunotherapy has shown clinical benefit for some cancer patients, other patients do not respond. One of the mechanisms of resistance to checkpoint inhibitors may be chemokine signaling. The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis). However, there are some reports that show involvements of this axis in tumor growth and metastasis (autocrine axis). Thus, a better understanding of CXCL9, -10, -11/CXCR3 axis is necessary to develop effective cancer control.

CXCR3分子の別称

CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
OCU-110OCU-10-C-110; OGX-110; OCU-110Phase 1 ClinicalOcugenix CorpMacular Degeneration
詳細
ACT-777991ACT-777991Phase 1 ClinicalIdorsia Pharmaceuticals LtdDiabetes Mellitus, Type 1; Inflammation
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8